-
Mashup Score: 0Richard Furie, MD: The Difficulty in Finding Lupus Treatments - 4 year(s) ago
Dr. Richard Furie explains the link between systemic lupus erthematosus and COVID-19.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Richard Furie, MD: The Difficulty in Finding Lupus Treatments - 4 year(s) ago
Dr. Richard Furie explains the link between systemic lupus erthematosus and COVID-19.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Dr. Vibeke Strand discusses the relationship between COVID-19 and psoriatic arthritis.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3
Biologic and targeted synthetic DMARD use is associated with an elevated risk for herpes zoster in patients with rheumatoid arthritis compared with conventional synthetic DMARDs, according to research presented at the EULAR 2020 E-congress.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1EULAR 2020 highlights: Fernando Pérez-Ruiz - 4 year(s) ago
Fernando Pérez-Ruiz discusses some of the key gout and crystal arthritis studies presented at the EULAR 2020 E-Congress (8:10).
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Quantitative computed tomography analysis has the potential to identify patients with systemic sclerosis-associated interstitial lung disease with a high 10-year mortality risk
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
An exploratory biomarker analysis of the EQUATOR study suggests that filgotinib treatment leads to a reduction in inflammation in patients with moderate-to-severe psoriatic arthritis.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1EULAR 2020 highlights: Oliver FitzGerald - 4 year(s) ago
Oliver FitzGerald outlines his highlights from the psoriatic arthritis presentations at the EULAR 2020 E-Congress, and discusses what the study results mean for clinical practice (10:13).
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Researcher comment: The JAKPOT study - 4 year(s) ago
Kim Lauper discusses findings from the JAKPOT study, an international collaboration showing comparable JAK inhibitor and TNF inhibitor retention rates in real-world patients with rheumatoid arthritis (3:50).
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Patients who cannot tolerate cDMARDs may experience additional value from tocilizumab compared to adalimumab.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
In a #EULAR2020goesvirtual abstract, Dr. Richard Furie discusses new SLE treatments. https://t.co/g3J27BuOBO